BETA

BLUF is in public beta. Automated sourcing and summaries by the BLUF engine, monitored by our team. Summaries may contain errors — verify important details at the source. Not medical, legal or financial advice. Public beta — automated summaries may contain errors. Full disclaimer

BLUFSOURCED EVENT BRIEFLAST CHANGED
DRUGS, DEVICES & RECALLS • UNITED STATES

FDA testing finds undeclared tadalafil in recalled honey supplement

1 OUTLET UNITED STATESONGOING
NOT MEDICAL ADVICE

This brief summarizes public reporting and official announcements. Research findings may be preliminary. Talk to a qualified clinician before making health decisions.

BLUF

The FDA says laboratory testing found tadalafil, a prescription erectile-dysfunction drug, that was not declared in a honey dietary supplement; the product is being recalled. Tadalafil can cause a dangerous drop in blood pressure when taken with nitrate medicines.

WHAT IS VERIFIED — AND WHAT IS NOT

Source coverage is not proof of every claim. Confirmed means direct support from an official record; corroborated means matching reporting; reported means attributed but not independently verified here. Disputed details remain unresolved.

REPORTED

FDA laboratory testing identified undeclared tadalafil in a honey dietary supplement, prompting a recall.

The Hill
ASSESSED

Tadalafil is a prescription erectile-dysfunction drug and can dangerously lower blood pressure when combined with nitrate medicines.

WHO'S COVERING IT

HOW THIS BRIEF WAS MADE 1 outlet: 1 national. Automated sourcing and summaries by the BLUF engine. Corrections

CONFIDENCE: LOW · SOURCE GRADE B6Coverage from 1 independent outlet; no official record is among BLUF's sources yet; officials may be quoted in the reporting. Coverage breadth does not verify every claim; see claim-level sources. What B6 means

Why it matters

People who bought the supplement may be exposed to an undeclared prescription drug.

What happens next

The recall notice’s further details and any additional FDA action are not clear from the report.

REPORTING FROMThe Hill
The rest of this brief is for BLUF readers with a plan
  • The full picture: every consequence, and the dates and decisions to watch
  • Timeline of how the story developed
  • How 1 outlets cover it, side by side (1 reports)
  • Claims and evidence: what's confirmed, reported or disputed
  • Background and Ask BLUF questions about this story

Plus gives you unlimited full stories for $8 a month. See plans Already have a plan? Sign in.